Literature DB >> 32933748

The p105 NF-ĸB precursor is a pseudo substrate of the ubiquitin ligase FBXO7, and its binding to the ligase stabilizes it and results in stimulated cell proliferation.

Ronald G Udasin1, Yossi Gottfried1, Bertrand Fabre1, Beatrice Bercovich1, Tamar Ziv2, Aaron Ciechanover3.   

Abstract

The NF-κB transcription factor is involved in inflammation and cell proliferation, survival, and transformation. It is a heterodimer made of p50 or p52 and a member of the Rel family of proteins. p50 and p52 are derived from limited ubiquitin- and proteasome-mediated proteolytic processing of the larger precursors p105 and p100, respectively. Both precursors can be either processed or completely degraded by the ubiquitin-proteasome system. Previous work in our laboratory identified KPC1 as a ubiquitin ligase that mediates processing of p105 to the p50 subunit. Overexpression of the ligase leads to increased level of p50 with a resultant marked tumor-suppressive effect. In the present study, we identify FBXO7, a known ubiquitin ligase that binds to p105 and ubiquitinates it, but surprisingly, leads to its accumulation and to that of p65 - the Rel partner of p50 - and to increased cell proliferation. Importantly, a ΔF-Box mutant of FBXO7 which is inactive has similar effects on accumulation of p105 and cell proliferation, strongly suggesting that p105 is a pseudo substrate of FBXO7.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FBXO7; NF-κB; Protein degradation; Ubiquitin-proteasome system; p105

Year:  2020        PMID: 32933748     DOI: 10.1016/j.bbrc.2020.08.098

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  The F-box protein, FBXO7, is required to maintain chromosome stability in humans.

Authors:  Michaela C L Palmer; Nicole M Neudorf; Ally C Farrell; Tooba Razi; Zelda Lichtensztejn; Kirk J McManus
Journal:  Hum Mol Genet       Date:  2022-05-04       Impact factor: 5.121

2.  Analysis of the FBXO7 promoter reveals overlapping Pax5 and c-Myb binding sites functioning in B cells.

Authors:  Rebecca Harris; Suzanne Randle; Heike Laman
Journal:  Biochem Biophys Res Commun       Date:  2021-03-25       Impact factor: 3.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.